BioSpace News Archive

Codagenix Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced the expansion of its senior management team with three new appointments. Lisa Runco, Ph.D., has been named Director of Operations.

Chiesi USA, Inc. , the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced the launch of FDA-approved Bronchitol® (mannitol) inhalation powder, an add-on maintenance therapy to improve pulmonary function in cystic fibrosis (CF) patients 18 years of age and older.

AbbVie (NYSE:ABBV), a global research and development-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the treatment of adult patients with active psoriatic arthritis.

Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will present at the Lytham Partners Spring 2021 Investor Conference on Tuesday, March 30, 2021 at 1:15pm ET.

Resverlogix Corp. (“Resverlogix”) (TSX:RVX) announced today the publishing of an article, titled: “BET Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV-2 Infection”, in Cell, a high-impact scientific journal. This comes following completion of the peer-review process for previously announced findings. Cell is ranked first out of 298 journals in “Biochemistry & Molecular Biology” (Clarivate Analytics, 2019).

GT Biopharma, Inc. (NASDAQ: GTBP) a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary NK cell engager (TriKE™) protein biologic technology platform is pleased to announce updated interim Phase I/II clinical trial results for the Company’s lead therapeutic candidate, GTB-3550,

BioIQ, an analytics-driven population health and testing platform company, introduces a first of its kind, end-to-end COVID-19 mitigation solution for employers, health plans, and government agencies.

Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced the availability of N95 medical-grade protective masks, one of the few, domestically manufactured N95 masks to receive Health Canada certification.

Ambrx, a clinical stage biopharmaceutical company using an expanded genetic code to create Engineered Precision Biologics, today announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for ARX788 for the treatment of patients with HER2-positive gastric cancer, including cancer at the gastroesophageal junction.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2020 financial and operating results on Thursday, March 25, 2021, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m.